PTGX

NASDAQ · Biotechnology

Protagonist Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$146.15

+8.83 (+6.43%)

PTGX News1 articles

NextCure Shares Skyrocket on Merger Deal, But Investors Eye Cash Payout

NextCure shares jumped 176.6% on merger news with Avere Therapeutics, but existing holders will own just 1.21% of the combined firm, focusing on a possible cash payout.